I agree that this site is using cookies. You can find further informations here.
X
Castagneto, B.
48  results:
Search for persons X
?
1

The importance of negative predictive value (NPV) of vulner..:

Castagneto, B. ; Di Pietrantonj, C. ; Stevani, I....
Medical Oncology.  30 (2013)  4 - p. , 2013
Link: https://doi.org/10.1007/..
 
?
2

An Italian enquiry on the organisation of the clinical acti..:

Monfardini⁎, S. ; Gridelli, C. ; Biganzoli, L....
Journal of Geriatric Oncology.  3 (2012)  - p. S77-S78 , 2012
Link: https://doi.org/10.1016/..
 
?
3

Assessment and treatment of elderly people with cancer: Ita..:

Colloca⁎, G. ; Carreca, I. ; Monfardini, S....
Journal of Geriatric Oncology.  3 (2012)  - p. S71-S72 , 2012
Link: https://doi.org/10.1016/..
 
?
4

Sorafenib (SFB) flat dose (FD) in frail elderly patients (F..:

Carreca, I. ; Castagneto, B. ; Condemi, G....
Journal of Geriatric Oncology.  3 (2012)  - p. S70-S71 , 2012
Link: https://doi.org/10.1016/..
 
?
5

The importance of negative predictive value for the accurac..:

Castagneto⁎, B. ; Dipietrantonj, C. ; Stevani, I....
Journal of Geriatric Oncology.  3 (2012)  - p. S71 , 2012
Link: https://doi.org/10.1016/..
 
?
6

Sustained response following sorafenib therapy in an older ..:

Castagneto, B. ; Stevani, I. ; Giorcelli, L....
Medical Oncology.  28 (2010)  4 - p. 1384-1388 , 2010
Link: https://doi.org/10.1007/..
 
?
7

6542 POSTER FISH and immunohistochemical analysis of PTEN i..:

Betta, P.G. ; Libener, R. ; Salvio, M....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 370 , 2007
Link: https://doi.org/10.1016/..
 
?
8

191 Pemetrexed in combination with carboplatin in elderly p..:

Ceresoli, G.L. ; Castagneto, B. ; Zucali, P.A....
Lung Cancer.  54 (2006)  - p. S46 , 2006
Link: https://doi.org/10.1016/..
 
?
9

O2 Pemetrexed in combination with carboplatin in elderly pa..:

Castagneto, B. ; Santoro, A. ; Ceresoli, G.L....
Critical Reviews in Oncology/Hematology.  60 (2006)  - p. S18 , 2006
Link: https://doi.org/10.1016/..
 
?
10

IL6, TNF-ALFA and IL1-beta as biochemical markers of malign..:

Mutti, L. ; Gatti, E. ; Lazzaro, A....
Lung Cancer.  15 (1996)  2 - p. 266 , 1996
Link: https://doi.org/10.1016/..
 
?
11

Intracavitary and systemic rIL-2 in the treatment of malign..:

Castagneto, B. ; Botta, M. ; De Giovanni, D...
Lung Cancer.  15 (1996)  2 - p. 265 , 1996
Link: https://doi.org/10.1016/..
 
?
12

Recombinant Interferon Alpha-2b in the Treatment of Diffuse..:

Ardizzoni, A. ; Pennucci, M. C. ; Castagneto, B....
American Journal of Clinical Oncology.  17 (1994)  1 - p. 80-82 , 1994
Link: https://doi.org/10.1097/..
 
?
13

ONJ (osteonecrosis of jaw) after short-term treatment with ..:

Fusco, V ; Fasciolo, A ; Castagneto, B..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
14

Oncogeriatry: Communication, sharing, coordination of an em..:

Barbieri, G ; Biganzoli, L ; Castagneto, B...
volume:19.  , 2010
Link: http://hdl.handle.net/10..
 
?
15

Single-agent pemetrexed for chemonaïve and pretreated patie..:

Taylor P ; Castagneto B ; Dark G...
info:eu-repo/semantics/altIdentifier/pmid/18594323.  , 2008
Link: http://hdl.handle.net/23..
 
1-15